Initially, the investigation was focused on the use of HpD as a fluorescent diagnosis agent, but in 1966 Lipson et al. [127] informed of the destruction of malignant tumors in patients with extended and recurrent ulcerated mammary gland cancer, which were exposed to xenon-lamp radiation after HpD was injected to them. This evidence concerns the gene HPD and cancer.